Further work demonstrated decreased T cell proliferation and IL-2 production upon stimulation by the T cell receptor (74) indicating that DAPK can interfere with T cell activation which might have important implications for chronic inflammatory diseases such as IBD. This evidence concerns the gene DAPK1 and inflammatory bowel disease.